Million+ Patients Helped

Incontinence Pelvalon

Jake Brenner

Co-Founder

Biodesign Innovation Fellow 2008-09

Steve Herbowy

Co-Founder & VP R&D

Biodesign Innovation Course Alumnus 2004-05

Miles Rosen

Co-Founder & CEO

Biodesign Innovation Course Alumnus 2008-09

"We were shocked to learn that fecal incontinence affects so many young, active women. Nobody talks about it, but eight million women in the US alone have regular bowel accidents. Often times, the problem stems from damage caused by pregnancy or childbirth. The condition strips women of control in their lives, forcing them to give up careers, social engagements, and exercise. The uncertainty and fear associated with their loss of bowel control can be debilitating and isolating.

When we started working in this space there were few solutions available. Doctors typically recommended dietary changes, exercise, or over-the-counter medications. If the issue persisted, the only other options were invasive and costly treatments such as surgery, surgical implants, or injections.

We developed a new, non-surgical option for these women that’s as easy and comfortable as other commonly- used female products. As one patient described, 'It’s scary to walk around without knowing if something is going to happen, but I am now back to being me – back to my walks, going out, and being social. I feel excited about it and I want other women to understand that there is hope.' Another woman shared her experience in a letter to her doctor (see image). If we can help more women like this reclaim their lives, that’s what it’s all about."

Incontinence

 

“The condition strips women of control in their lives. The uncertainty and fear can be debilitating and isolating.”

Pelvalon is dedicated to developing innovative solutions for women suffering from loss of bowel control to help improve their quality of life. The company’s first product, the Eclipse System, is currently available in select US treatment facilities.

Disclaimer of Endorsement: All references to specific products, companies, or services, including links to external sites, are for educational purposes only and do not constitute or imply an endorsement by the Byers Center for Biodesign or Stanford University.

Previous Read More Stories Next